Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 2
2018 5
2019 13
2020 6
2021 13
2022 10
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Different pain phenotypes are associated with anti-Caspr2 autoantibodies.
Greguletz P, Plötz M, Baade-Büttner C, Bien CG, Eisenhut K, Geis C, Handreka R, Klausewitz J, Körtvelyessy P, Kovac S, Kraft A, Lewerenz J, Malter M, Nagel M, von Podewils F, Prüß H, Rada A, Rau J, Rauer S, Rößling R, Seifert-Held T, Siebenbrodt K, Sühs KW, Tauber SC, Thaler F, Wagner J, Wickel J, Leypoldt F, Rittner HL, Sommer C, Villmann C, Doppler K; GENERATE study group. Greguletz P, et al. J Neurol. 2024 May;271(5):2736-2744. doi: 10.1007/s00415-024-12224-4. Epub 2024 Feb 22. J Neurol. 2024. PMID: 38386048 Free PMC article.
K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies.
Nelke C, Müntefering T, Cengiz D, Theissen L, Dobelmann V, Schroeter CB, Block H, Preuße C, Michels APE, Lichtenberg S, Pawlitzki M, Pfeuffer S, Huntemann N, Zarbock A, Briese T, Kittl C, Dittmayer C, Budde T, Lundberg IE, Stenzel W, Meuth SG, Ruck T. Nelke C, et al. Among authors: pfeuffer s. J Autoimmun. 2024 Jan;142:103136. doi: 10.1016/j.jaut.2023.103136. Epub 2023 Nov 5. J Autoimmun. 2024. PMID: 37935063 Free article.
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.
Pfeuffer S, Rolfes L, Ingwersen J, Pul R, Kleinschnitz K, Korsen M, Räuber S, Ruck T, Schieferdecker S, Willison AG, Aktas O, Kleinschnitz C, Hartung HP, Kappos L, Meuth SG. Pfeuffer S, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 11;10(3):e200104. doi: 10.1212/NXI.0000000000200104. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37041077 Free PMC article.
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis.
Schroeter CB, Rolfes L, Gothan KSS, Gruchot J, Herrmann AM, Bock S, Fazio L, Henes A, Narayanan V, Pfeuffer S, Nelke C, Räuber S, Huntemann N, Duarte-Silva E, Dobelmann V, Hundehege P, Wiendl H, Raba K, Küry P, Kremer D, Ruck T, Müntefering T, Budde T, Cerina M, Meuth SG. Schroeter CB, et al. Among authors: pfeuffer s. J Neuroinflammation. 2022 Nov 8;19(1):270. doi: 10.1186/s12974-022-02588-7. J Neuroinflammation. 2022. PMID: 36348455 Free PMC article.
Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis.
Pfeuffer S, Müntefering T, Rolfes L, Straeten FA, Eichler S, Gruchot J, Dobelmann V, Prozorovski T, Görg B, Vucur M, Berndt C, Küry P, Ruck T, Bittner S, Bettenworth D, Budde T, Lüdde T, Meuth SG. Pfeuffer S, et al. Cell Mol Gastroenterol Hepatol. 2022;14(6):1199-1211. doi: 10.1016/j.jcmgh.2022.08.003. Epub 2022 Aug 13. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35973573 Free PMC article.
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study.
Rolfes L, Pfeuffer S, Huntemann N, Schmidt M, Su C, Skuljec J, Aslan D, Hackert J, Kleinschnitz K, Hagenacker T, Pawlitzki M, Ruck T, Kleinschnitz C, Meuth SG, Pul R. Rolfes L, et al. Among authors: pfeuffer s. Mult Scler Relat Disord. 2022 Aug;64:103931. doi: 10.1016/j.msard.2022.103931. Epub 2022 May 29. Mult Scler Relat Disord. 2022. PMID: 35690010 Free article.
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
Ruck T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, Steffen F, Nelke C, Schroeter CB, Willison A, Heming M, Müntefering T, Melzer N, Krämer J, Lindner M, Riepenhausen M, Gross CC, Klotz L, Bittner S, Muraro PA, Schneider-Hohendorf T, Schwab N, Meyer Zu Hörste G, Goebels N, Meuth SG, Wiendl H. Ruck T, et al. Among authors: pfeuffer s. Brain. 2022 Jun 3;145(5):1711-1725. doi: 10.1093/brain/awac064. Brain. 2022. PMID: 35661859 Free PMC article.
50 results